Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Myelodysplastic Syndromes × Cyclophosphamide × Clear all

Sponsor

Conditions

Burkitt Lymphoma 3 Breast Neoplasms 3 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, B-Cell 2 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematologic Diseases 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1 Anemia 1

Interventions

Decitabine 3 decitabine and cedazuridine drug combination 2 cedazuridine 2 treosulfan 1 luspatercept 1 ivosidenib 1 imetelstat 1 glasdegib 1 enasidenib 1 GRN163L peptide 1 Daunorubicin 1 Cytarabine 1 Busulfan 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡